Loading…
Sai Life Sciences (SAILIFE)₹1,837+5.32%Pharmaceuticals
At the end of the Jun 2026 quarter, Sai Life Sciences' shareholders were: promoters 34.54%, FIIs 19.69%, DIIs 32.66%, public 13.11%. Promoter holding is down 0.08 percentage points from 34.62% a quarter earlier. FII holding is up 5.08 percentage points from 14.61% a year earlier. 0.00% of promoter shares were pledged. It had 1,25,144 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 35.24% | 35.17% | 35.16% | 34.96% | 34.71% | 34.62% | 34.54% |
| FIIs | 11.76% | 12.40% | 14.61% | 22.54% | 21.45% | 21.21% | 19.69% |
| DIIs | 11.90% | 13.21% | 21.59% | 29.87% | 31.36% | 31.49% | 32.66% |
| Public | 41.10% | 39.22% | 28.64% | 12.63% | 12.48% | 12.68% | 13.11% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,81,192 | 1,40,731 | 1,26,429 | 1,19,751 | 1,14,864 | 1,17,572 | 1,25,144 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| MYTREYI KANUMURI Partner of Marigold Partners (Partnership Firm) | Promoter | 10.49% | −0.03 |
| Invesco India Manufacturing Fund | DII | 7.48% | New |
| RANGA RAJU KANUMURI Partner of Sunflower Partners (Partnership Firm) | Promoter | 7.31% | −0.01 |
| Nippon Life India Trustee Ltd A/C Nippon India Mnc | DII | 6.72% | +0.50 |
| Gokaraju Subba Raju | Promoter | 4.53% | −0.01 |
| MYTREYI KANUMURI Partner of Tulip Partners (Partnership Firm) | Promoter | 4.38% | −0.01 |
| RANGA RAJU KANUMURI Partner of Lily Partners (Partnership Firm) | Promoter | 3.26% | −0.01 |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual F | DII | 2.91% | −0.04 |
| Aditya Birla Sun Life Trustee Private Limited A/C | DII | 2.74% | +0.50 |
| Smallcap World Fund, Inc | FII | 2.56% | −0.01 |
| Sai Quest Syn Private Limited | Promoter | 2.15% | −0.01 |
| Hsbc Mutual Fund - Hsbc Aggressive Hybrid Fund | DII | 1.87% | 0.00 |
| Anitha Rudraraju Nandyala | Public | 1.56% | −0.05 |
| Axis Max Life Insurance Limited A/C Uegfh - High G | DII | 1.55% | New |
| Krishnam Raju Kanumuri . | Promoter | 1.41% | 0.00 |
| Goldman Sachs Funds - Goldman Sachs India Equity P | FII | 1.24% | −0.18 |
| Mirae Asset Small Cap Fund | DII | 1.17% | New |
| Blackrock Startegic Funds - Blackrock Emerging Mar | FII | 1.11% | −0.18 |
| Dsp Healthcare Fund | DII | 1.07% | New |
| Gokaraju Lakshmi Tanuja | Promoter | 0.63% | 0.00 |
| Sudha Kanumuri . | Promoter | 0.24% | 0.00 |
| Ranga Raju Kanumuri | Promoter | 0.08% | 0.00 |
| Mytreyi Kanumuri | Promoter | 0.03% | 0.00 |
| Continental Wines P Ltd | Promoter | 0.01% | 0.00 |
| Invesco India Business Cycle Fund | DII | Exited | — |
Promoters held 34.54% of Sai Life Sciences at the end of the Jun 2026 quarter, down 0.62 percentage points from 35.16% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 19.69% (down 1.52 percentage points from 21.21% a quarter earlier) and domestic institutions (DIIs) held 32.66% (up 1.17 percentage points from 31.49% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Sai Life Sciences had 1,25,144 shareholders at the end of the Jun 2026 quarter, against 1,26,429 a year earlier.
Invesco India Manufacturing Fund (DII) held 7.48% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.